Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects

Trial Identifier: D2911C00001
Sponsor: AstraZeneca
NCTID:: NCT04588727
Start Date: October 2020
Primary Completion Date: January 2022
Study Completion Date: January 2022
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation
Simplified Chinese (China) Translation

Trial Locations

Country Location
US, CA Glendale, CA, US, 91206